Provided by Tiger Trade Technology Pte. Ltd.

AKESO

105.700
-3.400-3.12%
Volume:11.04M
Turnover:1.19B
Market Cap:97.35B
PE:-85.74
High:111.500
Open:110.900
Low:104.900
Close:109.100
52wk High:156.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:1.84
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.233
ROE:-13.59%
ROA:-4.57%
PB:9.80
PE(LYR):-85.74
PS:24.10

Loading ...

Movement Alert|Akeso Rises 3.32% in Regular Trading, Innovative Drug Payment Reform Continues to Catalyze Amid Sector-Wide Strength

Market Focus
·
Jul 06

Movement Alert|Akeso Inc Rises 4.8% in Regular Trading, Innovative Drug Payment Reform Catalyzes Biotech Sector Rally

Market Focus
·
Jul 03

Movement Alert|Akeso Bio Rises 6.3% in Regular Trading, Biotech Sector Rally and AI Drug Platform Progress Fuel Rebound

Market Focus
·
Jul 02

Movement Alert|Akeso Falls 3.06% in Regular Trading, Technical Profit-Taking After Previous Session 13% Rally Amid Sector-Wide Weakness

Market Focus
·
Jun 30

Akeso Shareholders Back 2025 Financial Statements at Annual Meeting

Reuters
·
Jun 29

Innovative Drug Sector Surges, Leading Market Rebound with Key ETFs and Stocks Soaring

Deep News
·
Jun 29

Movement Alert|Akeso Bio Rises 3.66% in Regular Trading, Ivonescimab Tops Evaluate Global Most Valuable Pipeline Ranking

Market Focus
·
Jun 29

Movement Alert|Akeso Falls 3.16% in Regular Trading, Post-ASCO Profit-Taking Continues as Stock Nears 52-Week Low

Market Focus
·
Jun 26

Movement Alert|Akeso Falls 3.43% in Regular Trading, Post-ASCO Profit-Taking Persists as Biotech Sector Weakens Again

Market Focus
·
Jun 25

Movement Alert|Akeso Rises 3.1% in Regular Trading, Multiple Brokerages Issue Buy Ratings Amid Biotech Sector Rebound

Market Focus
·
Jun 24

Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies

Stock News
·
Jun 23

China Securities Research Initiates Coverage on AKESO with a "Buy" Rating, Citing Multiple Growth Drivers

Stock News
·
Jun 23

Movement Alert|Akeso Rises 3.44% in Regular Trading, Buyback Support and Broker Buy Rating Trigger Rebound Near 52-Week Low

Market Focus
·
Jun 23

Movement Alert|Akeso Inc Falls 3.88% in Regular Trading, Sustained Selling Pressure Post-ASCO Data as Buyback Fails to Reverse Trend

Market Focus
·
Jun 22

Akeso (SEHK:9926) Stock Could Be 49% Undervalued After New AML Trial Data

Simply Wall St.
·
Jun 19

Movement Alert|Akeso Rises 3.64% in Regular Trading, Industry Buyback Wave and Sector Oversold Rebound Support Price Stabilization

Market Focus
·
Jun 18

Akeso says Phase II trial shows ligufalimab plus azacitidine, venetoclax extends event-free survival in frontline AML

Reuters
·
Jun 17

Movement Alert|Akeso Falls 3.41% in Regular Trading, Buyback Plan Fails to Halt Post-ASCO Profit-Taking Pressure

Market Focus
·
Jun 16

Akeso enrolls first patient in Phase Ib/II study of HER3 ADC AK138D1 plus ivonescimab in advanced breast cancer

Reuters
·
Jun 15

Akeso's Next-Generation Her3 ADC Ak138d1 Combined With Ivonescimab: First Patient Enrolled in Phase Ib/Ii Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy

THOMSON REUTERS
·
Jun 15